Blue Owl Capital Holdings »

Korro Bio shares owned by Blue Owl Capital Holdings

Quarter-by-quarter ownership of Korro Bio (KRRO) shares owned by Blue Owl Capital Holdings from 13F filings

Historical chart of Blue Owl Capital Holdings investment in Korro Bio

Tip: Access up to 7 years of quarterly data

All positions including Korro Bio held by Blue Owl Capital Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Korro Bio by Blue Owl Capital Holdings

Quarter filed Position value Share count Share price at filing
2025-09-30 $5.0M 105k 47.89
2025-06-30 $1.6M 125k 12.49

More positions owned by Blue Owl Capital Holdings

Nuveen Churchill Direct Lend Com Shs (NCDL)
Owl Rock Capital Corporation (OBDC)
Engene Holdings (ENGN)
Larimar Therapeutics (LRMR)
Evercommerce (EVCM)
Holley (HLLY)
Roivant Sciences SHS (ROIV)
Cullinan Oncology (CGEM)
Ultragenyx Pharmaceutical (RARE)
Conduent Incorporate (CNDT)
Sagimet Biosciences Com Ser A (SGMT)
Compass Therapeutics (CMPX)
Dell Technologies CL C (DELL)
Civeo Corp Cda Com New (CVEO)
Context Therapeutics (CNTX)

View all positions for Blue Owl Capital Holdings

Top funds holding Korro Bio

Atlas Venture Life Science Advisors
NEA Management Company
Driehaus Capital Management
FMR
Point72 Asset Management
Cormorant Asset Management
BlackRock
Siren
TCG Crossover Management
Vanguard Group
Qiming U.S. Ventures Management
Tri Locum Partners
72 Investment Holdings
Polar Capital Holdings
Millennium Management

View all funds holding Korro Bio